✨ Free AI Report
Aclarion, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Aclarion, Inc.
Company Research

Aclarion, Inc.: Business Overview, Financials & Competitive Analysis

Aclarion, Inc. scores 4/10 on the AskCyborg Cyborg Score (Mixed). Pre-revenue clinical-stage company with unique MRS biomarker technology; high risk/reward profile dependent on CLARITY trial data and clinical adoption. Aclarion is an early-stage healthcare technology company with innovative MRS-based diagnostic technology for spinal pain assessment. However, the company is unprofitable (negative EPS of -13.61), has a micro-cap valuation (~$7.6M), and.

What is Aclarion, Inc.'s industry? Aclarion, Inc. (aclarion.com) operates in Medical Devices. AskCyborg classifies Aclarion, Inc. under Medical Devices in its company registry.

Aclarion operates as a healthcare technology company that uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabiliti...

4/ 10Mixed

Cyborg Score thesis

Pre-revenue clinical-stage company with unique MRS biomarker technology; high risk/reward profile dependent on CLARITY trial data...

Read the full analyst-debate transcript →
Industry Medical Devices
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 7, 2026
AI-Verified Research
30+ Page Report

Get the Latest Aclarion, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Aclarion, Inc.

AskCyborg analysts argue the bull and bear cases for Aclarion, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Aclarion, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Aclarion, Inc. Overview

Pro stress-test →

Aclarion operates as a healthcare technology company that uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine.

Strategic Profile

Pro stress-test →

Aclarion offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that processes MRS exam data into final spectra and performs degenerative pain biomarker calculations, and NOCIGRAM, which processes results into NOCISCORES on a 0-10 scale. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for scanning intervertebral discs which extends the time of a standard lumbar MRI exam, and imaging data transfer products including AMBRA Healthcare.

Competitive Landscape

Pro stress-test →

Aclarion operates in the specialty diagnostic imaging and pain management technology space with limited direct competitors offering MRS-based spinal biomarker analysis. Broader competitors include general orthopedic diagnostics companies and pain management technology providers. The company's NOCISCAN platform represents a differentiated approach to identifying degenerative disc disease biomarkers.

Industry Context

Aclarion, Inc. operates in Medical Devices.

Key facts

Founded: 2008 · Headquarters: Broomfield, Colorado · Employees: N/A · Revenue: N/A · Market cap: $7.6M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Aclarion, Inc..

  • Aclarion changed its name from Nocimed, Inc. in December 2021, reflecting a rebranding and strategic evolution
  • Company is focused on degenerative disc disease and discogenic pain, a significant unmet clinical need in spinal care
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Participating in 38th Annual ROTH Conference, highlighting key 2026 catalysts and strong balance sheet
  • May 2026Announced issuance of U.S. Patent #12,601,803 for machine learning platform analyzing biomarkers
  • +2 moreTrack every material event for Aclarion, Inc. as it happens. Explore monitoring →
Get alerted when Aclarion, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

General orthopedic diagnosticsSpinal implants and orthopedic devices→MRI and imaging softwareMedical imaging platforms and solutions→Pain management diagnosticsPain assessment and management solutions→

Compare Aclarion, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Aclarion, Inc. operates in Medical Devices. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices research →
NEW · MCP server

Ask your AI assistant about Aclarion, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Aclarion, Inc. and its top competitor on Cyborg Score”
“What did Aclarion, Inc. do this quarter?”
“Is Aclarion, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Aclarion, Inc. do?+
Aclarion operates as a healthcare technology company that uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabiliti...
What is Aclarion, Inc.'s Cyborg Score?+
Aclarion, Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Aclarion, Inc.'s main competitors?+
Named competitors include General orthopedic diagnostics, MRI and imaging software, Pain management diagnostics. The full competitive landscape is in the AskCyborg report.
How can I get the full Aclarion, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Aclarion, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Aclarion, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Medical Devices research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Ambu A/S6Anika Therapeutics, Inc.6Pulse Biosciences, Inc.6Supermax Corporation Berhad5PolyNovo Limited4Know Labs, Inc.3SeaStar Medical Holding Corporation2Talis Biomedical Corporation